Project Grant RF1AG079569
Award Date
8/15/22
Completion Date
7/31/25
Dollars Obligated
$8.7M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award, funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), provides $1,858,368.00 to Brigham & Women's Hospital Inc. for the period of Sep 30, 2024 to Aug 31, 2027. The award supports research on the role of the SORL1-retromer biology in the pathogenesis of Alzheimer's disease. The research will be conducted by Brigham & Women's Hospital Inc., a prominent academic medical center and research institution affiliated with...
This $1,611,000 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Brigham & Women's Hospital Inc. aims to illuminate the role of somatic mutations in the development of primary tauopathies, a group of neurodegenerative diseases including Alzheimer's. The project will leverage single-cell whole-genome sequencing of human brain tissue to examine somatic mutations in neurons and glia, as well as utilize cellular models to dissect mechanisms...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $2,683,965.00 to Brigham & Women's Hospital Inc. to develop and optimize an improved "brain-chip" system for studying Alzheimer's disease (AD) and related dementias (ADRDs). The key objectives of this 3-year project, which runs from May 2025 to April...
This $885,006 project grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop a smartphone-based point-of-care diagnostic system to detect Alzheimer's disease (AD) biomarkers, including amyloid-beta, phosphorylated tau, and neurofilament light chain, in blood plasma. The primary recipient, Brigham & Women's Hospital Inc., will leverage microfluidics, nanotechnology, optical sensing, and deep learning to create an affordable, user-friendly test that can...
This $2,173,794 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate mechanisms by which adult hippocampal neurogenesis (AHN) and brain-derived neurotrophic factor (BDNF) can serve as therapeutic agents to slow cognitive decline in Alzheimer's disease (AD). The project, led by The General Hospital Corporation (doing business as Massachusetts General Hospital), aims to: 1) explore how AHN cooperates with BDNF and test whether...
The National Institutes of Health National Institute on Aging awarded $3,024,000 under the Aging Research federal grant program (CFDA 93.866) to the Massachusetts General Hospital on September 30, 2022 for a project concluding on August 31, 2025. The award will support research into discovering sex-linked genes on the inactive X chromosome that may influence female vulnerability to Alzheimer's disease pathology. The awardee will employ genomic, transcriptomic, and epigenetic analysis to...
The National Institute on Aging (NIA), part of the National Institutes of Health within the Department of Health and Human Services, awarded a $2,567,371 Project Grant to The Trustees of Columbia University in the City of New York under the Aging Research program (CFDA 93.866). The grant will fund research from May 1, 2022 to April 30, 2025 to identify cell type-specific autonomous and non-autonomous interactions in Alzheimer's disease (AD) using induced pluripotent stem cell (iPSC) lines from...
The National Institutes of Health's National Institute on Aging awarded a $5,063,226 Project Grant to Brigham and Women's Hospital Inc. under the Aging Research program (CFDA 93.866) for the period of September 1, 2022 through August 31, 2025. The grant funds research to analyze the functional role of glial cells in tauopathy and Alzheimer's disease. Researchers will use genetic approaches in Drosophila to identify glial proteins and pathways that influence tau neurotoxicity in aging adult fly...
This $2,365,042 Project Grant award from the National Institute on Aging's Aging Research Program (CFDA 93.866) supports research to better understand the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The primary objectives are to leverage cross-national data from the U.S. and India to evaluate associations between neurodegenerative biomarkers, cognitive outcomes, and socioeconomic factors. Key project activities include developing harmonized measures for...
This $3.61 million project grant from the National Institutes of Health's National Institute on Aging will fund research from July 2022 to June 2025 aimed at understanding and addressing neurovascular coupling dysfunction in Alzheimer's disease and Alzheimer's disease-related dementias. Specifically, the University of Colorado Denver will investigate the hypothesis that restoring neurovascular coupling can mitigate synaptic plasticity deterioration in the hippocampus and its behavioral...